Angelman Syndrome is a rare genetic disorder - so rare that you, and in fact many doctors and health professionals, have probably never heard of it.  

Our family now has first-hand experience, our grandson Hamish was recently diagnosed with Angelman Syndrome. He is a dear affectionate little boy full of smiles and chuckles..

Children born with this disorder will need lifelong care.  They will have serious motor and co-ordination issues, might never walk, most will never speak and be prone to seizures.  

There is hope for them however.  Scientists believe that Angelman Syndrome has the greatest potential for being cured when compared to other neurogenetic disorders. Worldwide there are several research projects looking for gene therapies or even a cure for this distressing condition with some promising signs of progress. As the pandemic has shown with enough finance and motivation the progress of medical innovations can be accelerated and the seemingly impossible achieved.

Naturally such research costs lots of money and naturally we want to help. We wonder if you might too, so we are launching this appeal. 

Thank you very much for your time reading this, and if you decide to help, your donation will be very much appreciated.

                         ________________

The Foundation for Angelman Syndrome Therapeutics UK (FAST UK) is an organisation of families and professionals dedicated to finding a cure for Angelman Syndrome and related disorders through the funding of an aggressive research agenda, education and advocacy. The Foundation is committed to raising awareness as well as assisting individuals to realise their full potential and quality of life. We are confident that our goals are within reach and together, with your help, we will change lives.

In the United States, research funded by FAST has identified a way to turn on a gene that is normally turned off in the brain. FAST US took this discovery and started its own biotechnology company to move this technology from the laboratory into human clinical trials. Trials were initiated in 2020 and early preliminary results suggest this therapeutic may effectively treat the symptoms of Angelman syndrome, and trials are underway in the UK already but funding is necessary for these trials to continue so please help today by donating today.

To find out more see https://cureangelman.org.uk/understanding-angelman-syndrome/